| Previous Close | 9.50 |
| Open | 9.45 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 9.35 - 9.56 |
| 52 Week Range | 4.27 - 9.94 |
| Volume | 818,624 |
| Avg. Volume | 472,942 |
| Market Cap | 1.15B |
| Beta | 0.58 |
| PE Ratio (TTM) | 40.64 |
| EPS (TTM) | 0.23 |
| Earnings Date | Aug 21, 2017 - Aug 25, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.50 |
- Accesswire•3 days ago
Featured Company News - Thermo Fisher's Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Gets Pre-market Approval from US FDA
Research Desk Line-up: China Cord Blood Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Thermo ...
- Associated Press•7 days ago
China Cord Blood posts 4Q profit
On a per-share basis, the Hong Kong-based company said it had net income of 7 cents. The provider of cord blood banking services posted revenue of $29.3 million in the period. For the year, the company ...
- PR Newswire•7 days ago
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2017
Added 20,566 New Subscribers in 4Q17 4Q17 Revenue Amounted to RMB 202.0 Million ($ 29.3 Million) 4Q17 Operating Income Amounted to RMB 56.3 Million ($ 8.2 Million) Conference Call to be Held on June 22 ...